ALPHAEON Appoints Board Of Directors


ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, appointed a team of prominent leaders in healthcare and business to its board of directors. The new board is comprised of experts from the healthcare industry, politics, science, and education. In addition, the Honorable Christopher Cox will serve as a special advisor to the board.

“I am delighted to welcome such an accomplished group of innovators and leaders to the ALPHAEON board,” said ALPHAEON Chief Executive Officer Robert E. Grant. “Each will add tremendous value as ALPHAEON continues its rapid expansion to become the leader in self-pay lifestyle healthcare.”

The ALPHAEON directors include:

William J. Link, PhD, chairman, has more than three decades of operations experience in the healthcare industry and a proven record of building and managing large, successful medical product companies. Dr. Link co-founded and presently serves as a managing director of Versant Ventures, which specializes in early-stage investment in healthcare technologies. He previously founded and served as the chairman and CEO of Chiron Vision, and founded and was president of American Medical Optics (AMO), now a division of Abbott.

Robert E. Grant, chief executive officer of ALPHAEON, presently serves as chairman and managing partner of Strathspey Crown Holdings, LLC, ALPHAEON's parent company. For more than 20 years, he has played a pivotal role in successful technology and business development in the pharmaceutical, medical device and healthcare markets. Most recently, he was CEO and president of Bausch + Lomb Surgical and also previously served as president of Allergan Medical, a division of Allergan, Inc.

Robert Hayman, founder & former chairman and chief executive officerof Discus Dental Inc., Culver City, CA, which develops and markets leading professional dental materials and small equipment in more than 100 countries. The company, founded in 1992, is known for its light-activated whitening systems Zoom and BriteSmile, as well as a range of devices and products in the professional dental arena. In December of 2010, Royal Philips Electronics acquired Discus Holdings, in an effort to expand the company's oral healthcare portfolio. Currently, Mr. Hayman serves as executive chairman of Hayman Advisors, LLC.

Hans Keirstead, PhD is an internationally known stem cell expert who has worked on stem cell-based therapies for late stage cancers, motor neuron diseases, spinal cord injury and retinal diseases. He has served as Founder, President and CEO of Ability Biomedical, where he led the development of an immunotherapy, which he sold to Bristol Myers Squibb, and later California Stem Cell, Inc. (“CSC”), which was acquired by NeoStem in May 2014. He currently serves as president of NeoStem Oncology. He founded the Sue and Bill Gross Stem Cell Research Center and served as Full Professor of Anatomy and Neurobiology. He is the recipient of the Distinguished Award for Research, the UCI Academic Senate's highest honor, as well as the UCI Innovation Award for innovative research leading to corporate and clinical development.

Richard L. Lindstrom, MD is founder and attending surgeon of Minnesota Eye Consultants and Adjunct Clinical Professor Emeritus at the University of Minnesota's Department of Ophthalmology; Associate Director of the Minnesota Lions Eye Bank and Visiting Professor at the University of California Irvine's Gavin Herbert Eye Institute. A board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive and laser surgery, Dr. Lindstrom is past president of the American Society of Cataract and Refractive Surgeons and past president of the International Society of Refractive Surgery. Dr. Lindstrom currently serves on the Board of Directors of AcuFocus Inc., TLC Vision, TearLab, Refractec, Wavetec, Encore, RevitalVision, and the University of Minnesota Foundation.

Vikram Malik is a managing partner in the growth equity firm Strathspey Crown Holdings LLC. During a 26-year career on Wall Street, Mr. Malik recently served as vice chairman of Investment Banking and Global Head of Medical Technology at Deutsche Bank. Previously he was managing director in the Healthcare Corporate and Investment Banking Group at Bank of America Merrill Lynch. He has completed more than $100 billion in mergers and acquisitions, equity and financing transactions over his career.

Patrick Maxwell, MD is a clinical professor of plastic surgery at California's Loma Linda University and Vanderbilt University in Nashville, where he holds a post-graduate fellowship focusing on aesthetic and breast surgery. Dr. Maxwell, who also maintains a private practice, Maxwell Aesthetics, has published more than 140 scientific articles, holds 16 US patents for medical devices, co-founded Precision Light recently acquired by Allergan, and is a founder, principle in GID (an adipose/adipose-derived stem cell company). He also designed the Natrelle silicone gel collection of breast implants for Allergan, Inc., and founded and chairs the Allergan Academy.

Valerie Taupin is founder, chief executive officer and chairman of Geneva-based TEOXANE Laboratories, a leader in hyaluronic acid-based fillers currently sold in 90 countries outside the United States. She began her career marketing breast implants, lasers and medical devices and in 2000 formed the company, Leaderm, a division of Corneal SA., where she developed Juvederm, which wasexported to more than 50 countries and later acquired by Allergan. In August 2013, ALPHAEON acquired an exclusive US license for the full line of TEOXANE products.

Joseph Whitters, CPA is a seasoned director and corporate advisor. He currently serves on the board of directors of publicly traded PRGX Global, Inc. and InfuSystems Holdings, Inc., and is the former chairman of  Mentor, an aesthetic manufacturer that was sold to Johnson and Johnson in 2009. Previously, he served as chief financial officer at First Health Services Corp. During his tenure there, the company grew from $5 million to $900 million in revenue. First Health sold for $1.8 billion in 2005.

Senior Advisor and Board Observer Chris Cox, a former 17-year member of the US House of Representatives, is a partner in the international law firm Bingham McCutchen LLP and president of Bingham Consulting LLC. He advises global companies on strategic issues, corporate governance, securities regulation and general business. Mr. Cox served as the 28th chairman of the Securities and Exchange Commission and chairman of the Homeland Security Committee in the house. Previously, he served as White House counsel to President Ronald Reagan and as corporate partner at Latham & Watkins.


Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free